Australia Diabetes Therapeutics Market Analysis


  • Type: Common Disease Area
  • Published : April 2021
  • Region: APAC
  • Country: Australia
  • Report ID : 4137

  • Format: PPT, PDF

Australian Diabetes Therapeutics Market: Segmented by Drug class (Insulin, DPP- 4 Inhibitors, GLP- 1 Receptor Agonists, SGLT- 2 Inhibitors, & Others), by Device (Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps, and Injectors, Lancing Devices and Equipment, Continuous Glucose Monitoring Devices and Equipment, Blood Glucose Meters, & Others), & by Route of Administration (Oral, Intravenous, & Subcutaneous)- Growth, Trends, and Forecasts (2019 – 2028)


Report Overview

The Australian Diabetics Therapeutics market size stood at around USD 1.38 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Australia ranked seventh in the world for the prevalence of type 1 diabetes in children and 6th highest for incidence. There is also the rising prevalence of particularly type 2 diabetes and rising cases of children and adolescents who are now impacted by type 2 diabetes in Australia. Type 1 diabetes typically happens at an early age, it is the most common form of childhood diabetes although it can occur at any age. The prevalence of diabetes in Australia has skyrocketed three times to 4.2% over the last 25 years. Around 1 million people in the country suffer from diabetes and around 2 million have pre-diabetes. Of these, 11% have type 1 diabetes, 87% have type 2 diabetes, and 2% of women have gestational diabetes. It is estimated that approximately 3.4 million citizens will suffer from diabetes in the forecasted period.

Market Drivers

The growth is driven by the high prevalence of diabetes, acceptance, and proliferation of advanced patient compliant technologies increased reimbursement of devices and government subsidy on consumables. The market of Self-Monitoring Blood Glucose Device, Continuous Glucose Monitoring (CGM) Device, Insulin Pump, and Insulin Pen are growing due to the rising awareness for diabetes in Australia. Diabetes care in Australia has reached a high level of quality, but there is still an opportunity for further improvement. Diabetes is associated with an uncountable of complications that affect the eyes, feet, kidneys, and cardiovascular health. Besides, diabetes is ranked in the top 10 leading causes of death in Australia. Diabetes is a massive challenge to the nation’s health and economy.

Australian Government has essential roles in maintaining access to affordable, high-quality devices and services to support people with diabetes in self-management and treatment. The Australian Government providing support to people with diabetes through the National Diabetes Services Scheme, the Pharmaceutical Benefits Scheme, the Insulin Pump Program, and Medicare.

1. Australian Diabetes Market Overview…………………………………………………………..
A. Market Size
2. Market Growth Drivers……………………………………………..……………………….
A. High Prevalence of Diabetes
B. Rising awareness for diabetes
C. Growing R&D Investments and Reimbursement policies
3. Major Diabetes Diseases Types……………………………………………………….…
A. Type 1
B. Type 2
C. Gestational Diabetes
4. Diabetes Therapeutics Market Segmentation…………………………………………
A. Drug class
I. Insulin
II. DPP- 4 Inhibitors
III. GLP- 1 Receptor Agonists
IV. SGLT- 2 Inhibitors
V. Others
B. Device
I. Blood Glucose Test Strips
II. Insulin Pens, Syringes, Pumps, and Injectors
III. Lancing Devices and Equipment
IV. Continuous Glucose Monitoring Devices and Equipment
V. Blood Glucose Meters
VI. Others
C. Route of Administration
I. Oral
II. Intravenous
III. Subcutaneous
5. Diabetes Major Products Market Share…………………………………………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape………………………………………………..……………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………..…….
A. F. Hoffmann-La Roche AG company overview, Product & Services, Strategies & Financials
B. Johnson & Johnson Company overview, Product & Services, Strategies & Financials
C. Abbott Laboratories Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………….…………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………………
A. New Trends and Development of Diabetes market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Class:

The diabetes care drugs market is segmented by drugs into insulin (basal or long-acting, bolus or fast-acting, traditional human insulin drugs, and insulin biosimilars), oral anti-diabetic drugs (alpha-glucosidase inhibitors, DPP-4 inhibitors, and SGLT-2 inhibitors), non-insulin injectable drugs (GLP-1 receptor agonists, and Amylin Analogue), and combination drugs (combination insulin, oral combination). People with type 1 diabetes produce little or no insulin, so need lifelong insulin replacement. Some people with type 2 diabetes, and some women with gestational diabetes (diabetes during pregnancy), also need to use insulin. Most people with type 2 diabetes start treatment with metformin, a drug that reduces the amount of glucose released into your blood, and increases the amount taken up by your cells.

By Device:

The diabetes care devices (or) equipment consists of sales of diabetes care devices and related services by entities (organizations, sole traders, and partnerships) that produce diabetes care devices used to monitor blood glucose levels in diabetic patients. This industry includes establishments that produce blood glucose test strips used to check blood glucose levels, Insulin Pens, Syringes, Pumps and Injectors used to inject insulin, continuous glucose monitoring devices, blood glucose meters, and others.

By Route of administration:

Based on the route of administration, the diabetes drug market can be segmented into oral, subcutaneous, and intravenous. The hypertension segment is anticipated to grow due to the increasing prevalence of diabetes and many patients in the Australian demography.

Major Players

The diabetes drug market is moderately competitive and consists of several major players. A few of the key players covered in the Australian Diabetes Therapeutics market are F. Hoffmann-La Roche AG (ROG: SIX), Life Scan, Inc., a Johnson & Johnson Company (NYSE: JNJ) and Abbott Laboratories (NYSE: ABT) enjoy a major share of the market. Other players include Animas Corporation (Nasdaq: PUMP), ARKRAY, Inc., Bayer HealthCare AG (BAYN: DE), Becton, Dickinson, and Company (NYSE: BDX), Eli Lilly and Company (NYSE: LLY), Medtronic, Inc. (NYSE: MDT), Novo Nordisk A/S (Copenhagen: NOVOb.CO – Reuters; NYSE: NVO), Sanofi S.A. (SAN: EN; NYSE: SNY), Smiths Medical, a division of Smiths Group Plc (LSE: SMIN) and Terumo Corporation.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements